JPS5762277A - Manufacture of effect-enduring vincamine blend, obtained vincamine blend and medicine - Google Patents

Manufacture of effect-enduring vincamine blend, obtained vincamine blend and medicine

Info

Publication number
JPS5762277A
JPS5762277A JP56081923A JP8192381A JPS5762277A JP S5762277 A JPS5762277 A JP S5762277A JP 56081923 A JP56081923 A JP 56081923A JP 8192381 A JP8192381 A JP 8192381A JP S5762277 A JPS5762277 A JP S5762277A
Authority
JP
Japan
Prior art keywords
vincamine
blend
enduring
medicine
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP56081923A
Other languages
English (en)
Inventor
Chiyandora Kuhana Sateishiyu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of JPS5762277A publication Critical patent/JPS5762277A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D461/00—Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
JP56081923A 1980-06-23 1981-05-30 Manufacture of effect-enduring vincamine blend, obtained vincamine blend and medicine Pending JPS5762277A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH480480 1980-06-23

Publications (1)

Publication Number Publication Date
JPS5762277A true JPS5762277A (en) 1982-04-15

Family

ID=4282830

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56081923A Pending JPS5762277A (en) 1980-06-23 1981-05-30 Manufacture of effect-enduring vincamine blend, obtained vincamine blend and medicine

Country Status (15)

Country Link
EP (1) EP0042818A1 (ja)
JP (1) JPS5762277A (ja)
KR (1) KR830005853A (ja)
AU (1) AU7201781A (ja)
DD (1) DD159737A5 (ja)
DK (1) DK274081A (ja)
ES (1) ES8203891A1 (ja)
FI (1) FI811934L (ja)
GB (1) GB2078758A (ja)
GR (1) GR75708B (ja)
IL (1) IL63148A0 (ja)
NO (1) NO812039L (ja)
NZ (1) NZ197485A (ja)
PT (1) PT73238B (ja)
ZA (1) ZA814194B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62142175A (ja) * 1985-11-08 1987-06-25 コベツクス・ソシエダ・アノニマ （―）エブルナメニン―１４―（１５ｈ）―オン樹脂酸塩およびその製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE550150A (ja) * 1955-08-08
FR2201898A1 (en) * 1973-05-30 1974-05-03 Sogeras Vincamine arabogalactan sulphate - with prolonged activity for treating cerebrovascular disorders
FR2253507A1 (en) * 1973-12-11 1975-07-04 Houdet Antoine Vincamine administration using delayed release excipient - allowing prolonged action
FR2313915A1 (fr) * 1976-01-26 1977-01-07 Corneille Gilbert Nouvelle forme galenique d'administration de la vincamine et de ses derives, son procede de preparation et medicaments comprenant cette nouvelle forme
PT66201B (fr) * 1976-02-23 1978-11-07 Corvi Mora E Procede et composition pour la therapeutique des maladies circulatoires cerebrales

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62142175A (ja) * 1985-11-08 1987-06-25 コベツクス・ソシエダ・アノニマ （―）エブルナメニン―１４―（１５ｈ）―オン樹脂酸塩およびその製造方法
JPH0569837B2 (ja) * 1985-11-08 1993-10-01 Kobetsukusu Sa

Also Published As

Publication number Publication date
DK274081A (da) 1981-12-24
GR75708B (ja) 1984-08-02
ES503263A0 (es) 1982-04-01
NO812039L (no) 1981-12-28
KR830005853A (ko) 1983-09-14
NZ197485A (en) 1983-09-30
IL63148A0 (en) 1981-09-13
EP0042818A1 (de) 1981-12-30
ES8203891A1 (es) 1982-04-01
DD159737A5 (de) 1983-04-06
PT73238B (de) 1983-05-11
AU7201781A (en) 1982-01-07
ZA814194B (en) 1982-07-28
FI811934L (fi) 1981-12-24
PT73238A (de) 1981-07-01
GB2078758A (en) 1982-01-13

Similar Documents

Publication Publication Date Title
JPS57111349A (en) Polymer blend and manufacture
JPS5791921A (en) Medicine and manufacture
JPS57108090A (en) Novel nortropane and granatane derivatives, manufacture and use as medicine
JPS5750913A (en) Nifedipin-containing solid medicine and manufacture
JPS57128204A (en) Brasier and production thereof
ZA814225B (en) Quinazolines,their preparation and use
JPS5753473A (en) Novel n-aryl-2-oxazolidinones, manufacture and drug containing them
JPS56169690A (en) Xanthinederivative and manufacture
JPS5718624A (en) Drug and manufacture
JPS57192366A (en) Acylquinolinone derivative, manufacture, drug blend containing same and use
JPS5788172A (en) Pyroxicam and manufacture
JPS56131539A (en) Substituted bromfluorobenzene and manufacture
JPS56164191A (en) Theophyllinylmethyldioxolane derivative, its manufacture and medicine
JPS5711969A (en) 2-nitroimidazoles and manufacture
JPS57123173A (en) 3,4-b is-substituted 1,2,5-oxydiazole-2-oxide, manufacture and pharmaceutical blend containing same
JPS56150088A (en) Pyrimidyl-quinazoline,its manufacture and pharmaceutical blend containing it
JPS5795947A (en) Manufacture of alpha-hydroxy-carboxyamide, novel intermediate therefor and manufacture
JPS5731686A (en) Xanthine derivatives, manufacture and medicinal composition containing them
JPS56138154A (en) Desacetylthymosin-alpha-1 and manufacture
JPS5728059A (en) Novel dihydropyridazinone, manufacture and medicine containing same
JPS5751755A (en) Pigment blend and manufacture
JPS5762277A (en) Manufacture of effect-enduring vincamine blend, obtained vincamine blend and medicine
ZA813474B (en) Cardiotonic aminophenylpyridine derivatives and preparation
JPS56154476A (en) 4-halogenated-oxetane-2-ones and manufacture
DE3166751D1 (en) Pentapeptides of the encephaline type, process for their preparation and medicaments containing these